Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background & Aims Per- and polyfluoroalkyl substances (PFAS) are widespread pollutants with demonstrated hepatotoxicity. Few studies have examined the association between PFAS and fatty liver disease (FLD) risk in an adult population. Methods In this cross-sectional study of participants from the 2017–2018 National Health and Nutrition Examination Survey, serum PFAS were measured, and FLD cases were ascertained by vibration-controlled transient elastography. Logistic regression models were used to examine the association between circulating PFAS levels and FLD risk. Analyses were stratified into non-alcoholic FLD and alcoholic FLD risk groups by alcohol intake status, as well as controlling for other risk factors, including personal demographics, lifestyle factors, and related health factors. Results Among 1,135 eligible participants, 446 had FLD. For FLD risk, the multivariable-adjusted odds ratio per log-transformed SD increase (OR SD ) in perfluorohexane sulfonate (PFHxS) was 1.13 (95% CI 1.01–1.26). The association between PFHxS and FLD appeared stronger among individuals with obesity or high-fat diets (both p interaction <0.05). When limiting the analysis to 212 heavy drinkers (≥2 drinks/day for women and ≥3 drinks/day for men), significantly higher risk of alcoholic FLD was found for higher levels of perfluorooctanoic acid (OR SD 1.79; 95% CI 1.07–2.99), PFHxS (OR SD 2.06; 95% CI 1.17–3.65), and perfluoroheptane sulfonic acid (OR SD 1.44; 95% CI 1.00–2.07), and marginally significant higher risk for total PFAS (OR SD 2.12; 95% CI 0.99–4.54). In never or light drinkers, we did not observe any significant association between PFAS and non-alcoholic FLD. Significant positive associations were found for PFAS with aspartate aminotransferase, gamma-glutamyl transaminase, total bilirubin, and albumin (β ranged from 0.008 to 0.101, all p <0.05). Conclusions Higher serum PFAS was moderately associated with FLD risk and worse liver function in the general population, and among those with independent risk factors, including heavy alcohol intake, obesity, or high-fat diets, PFAS increased the risk. These results suggest synergistic effects on hepatic steatosis between PFAS exposures as measured through biomonitoring data and lifestyle risk factors in a nationally representative US population. Impact and Implications The per- and polyfluoroalkyl substances (PFAS) may convey higher risk for chronic liver disease in humans. Among 1,135 US adults in the 2017–2018 National Health and Nutrition Examination Survey, we found that higher serum PFAS was associated with higher fatty liver disease risk and worse liver function, especially among those with liver disease risk factors, including heavy alcohol intake, obesity, or high-fat diets. Continuously monitoring PFAS in the population and examining how they potentiate risk to the liver are essential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An overview of the uses of per- and polyfluoroalkyl substances (PFAS)
Glüge, J., Scheringer, M., Cousins, I. T., DeWitt, J. C., Goldenman, G., Herzke, D., Lohmann, R., Ng, C. A., Trier, X., & Wang, Z. (2020) · Environmental Science: Processes & Impacts · doi:10.1039/d0em00291g · Cited by 2,466
Per- and polyfluoroalkyl substances in the environment
Evich, M. G., Davis, M. J. B., McCord, J. P., Acrey, B., Awkerman, J. A., Knappe, D. R. U., Lindstrom, A. B., Speth, T. F., Tebes-Stevens, C., Strynar, M. J., et al. (2022) · Science · doi:10.1126/science.abg9065 · Cited by 2,157 · cited 1×
“In recent decades, alerts have been raised regarding their ubiquitous contamination, persistence, and potentially adverse effects on environmental and human health.(9)”
ACG clinical guideline: evaluation of abnormal liver chemistries
Kwo, P. Y., Cohen, S. M., & Lim, J. K. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.517 · Cited by 1,222 · cited 7×
“…by the US Food and Drug Administration for the non-invasive detection of more advanced diseases in patients who have FLD or who are at risk for FLD. 16 National efforts to phase out long-chain PFAS, 17 especially per fl uorooctanoic acid (PFOA) and per fl uorooctane sulfonic acid (PFOS), are…”
InfluentialCusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021 · cited 1×
“22 The controlled attenuation parameter score provides a measure of the portion of the liver affected by fatty change at the time of the procedure.”
Half-Lives of PFOS, PFHxS and PFOA after End of Exposure to Contaminated Drinking Water
Li, Y., Fletcher, T., Mucs, D., Scott, K., Lindh, C. H., Tallving, P., & Jakobsson, K. (2018) · Occupational and Environmental Medicine · doi:10.1136/oemed-2017-104651 · Cited by 815 · cited 2×
“30 Our study showed that the association with liver function persists at lower-level exposures of PFAS in the population over the past decade.”
Accumulation of perfluoroalkyl substances in human tissues
Pérez, F., Nadal, M., Navarro-Ortega, A., Fàbrega, F., Domingo, J. L., Barceló, D., & Farré, M. (2013) · Environment International · doi:10.1016/j.envint.2013.06.004 · Cited by 730 · cited 1×
“33,34 Mechanistic research regarding the PFAS contribution to liver mal-function and steatosis led to the following hypotheses.”
Past, present and future perspectives in nonalcoholic fatty liver disease
Sanyal, A. J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0144-8 · Cited by 522 · cited 1×
“Although excess alcohol intake, obesity, and diabetes are the leading causes of fatty liver disease (FLD), exposure to environmental contaminants may also contribute to this multifactorial disease.(5,6) The per- and polyfluoroalkyl substances (PFAS) are a group of structurally stable chemicals that are widely used to…”
Costello, E., Rock, S., Stratakis, N., Eckel, S. P., Walker, D. I., Valvi, D., Cserbik, D., Jenkins, T., Xanthakos, S. A., Kohli, R., et al. (2022) · Environmental Health Perspectives · doi:10.1289/ehp10092 · Cited by 420 · cited 3×
“10,11 However, although growing evidence implicates higher PFAS in abnormal liver biomarkers, for example, alanine aminotransferase (ALT), gamma-glutamyl transaminase (GGT), and bilirubin, 11 – 14 the speci fi c association with FLD, especially AFLD, and with advanced liver disease requires…”
Vilar‐Gomez, E., Nephew, L. D., Vuppalanchi, R., Gawrieh, S., Mladenovic, A., Pike, F., Samala, N., & Chalasani, N. (2022) · Hepatology · doi:10.1002/hep.32207 · Cited by 277 · cited 2×
“Strengths included a large representative sample, a comprehensive panel of liver function biomarkers, well-validated detection and quanti fi cation of steatosis using VCTE, 21,23,24 and strati fi cation analyses considering personal demographics, lifestyle factors, and liver-related metabolic factors.”
Chen, Z., Yang, T., Walker, D. I., Thomas, D. C., Qiu, C., Chatzi, L., Alderete, T. L., Kim, J. S., Conti, D. V., Breton, C. V., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.106091 · Cited by 176 · cited 1×
“35 However, these chemicals remain in use worldwide, reside in innumerable available products, 7 and are detectable in nearly all US adults and may persist in vivo for an extended period, with estimated half-lives of 2 – 6 years in the human body.”
Cited by
Yang, M., Su, W., Li, H., Li, L., An, Z., Xiao, F., Liu, Y., Zhang, X., Liu, X., Guo, H., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115473 · Cited by 23
Self-citationQiao, W., Li, J., Luo, L., Peng, W., Wang, X., Jin, R., & Li, J. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117436 · Cited by 16
Dui, W., Smith, M. P., & Bartock, S. H. (2024) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-024-05519-y · Cited by 9
Kim, C., Tagmount, A., Zhu, Z., Wilson, F., Li, D., Ostrov, D. A., Brad Barbazuk, W., Bacher, R., & Vulpe, C. D. (2026) · Archives of Toxicology · doi:10.1007/s00204-025-04294-8 · Cited by 1
Metadata
- Authors
- Zhang, X., Zhao, L., Ducatman, A., Deng, C., von Stackelberg, K. E., Danford, C. J., & Zhang, X.
- Venue
- JHEP Reports
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 5
- Issue
- 5
- Pages
- 100694
- ISSN
- 2589-5559 (ISSN-L)
- OpenAlex
- W4318939183
- Cited by
- 110
- References
- 12
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults. https://app.cochat.ai/papers/10.1016/j.jhepr.2023.100694
- The paper
- Zhang, X., Zhao, L., Ducatman, A., Deng, C., von Stackelberg, K. E., Danford, C. J., & Zhang, X. (2023). Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults. JHEP Reports. https://doi.org/10.1016/j.jhepr.2023.100694
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.